Skip to search formSkip to main contentSkip to account menu

Agomelatine

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2014
Highly Cited
2014
Calcium ion (Ca2+) is one of the universal second messengers, which acts in a wide range of cellular processes. Results of recent… 
2014
2014
Objective: Agomelatine is a new antidepressant with unique melatonin receptor type 1A (MTNR1A) and 1B ( MTNR1B) agonism and… 
2014
2014
A sensitive and selective LC-MS/MS method for the determination of agomelatine in human plasma was developed and validated. After… 
2013
2013
Objective A pooled-analysis on the long-term outcome in four head-to-head studies: agomelatine versus fluoxetine, sertraline, and… 
Highly Cited
2012
Highly Cited
2012
OBJECTIVE This study evaluated the efficacy and tolerability of agomelatine in the prevention of relapse in patients with… 
2012
2012
Abstract Introduction: The non-interventional study VIVALDI was carried out to evaluate the treatment with agomelatine, an… 
2012
2012
An analytical method based on liquid-liquid extraction has been developed and validated for analysis of agomelatine in human… 
Highly Cited
2011
Highly Cited
2011
RationaleNeuronal plasticity is associated with depression, probably as a result of modified expression of proteins important for… 
Highly Cited
2011
Highly Cited
2011
Agomelatine is a new antidepressant with a novel profile of pharmacological action. The clinical efficacy of agomelatine has been… 
Highly Cited
2003
Highly Cited
2003
RATIONALE AND METHOD Two doses of agomelatine (S-20098), a novel potential antidepressant drug with a new pharmacological profile…